ARTICLE | Clinical News
EPI-A0001: Phase I data
November 10, 2008 8:00 AM UTC
In a placebo-controlled Phase I trial in healthy volunteers, A0001 produced no drug-related serious adverse events. Penwest received exclusive rights to A0001 from Edison last year (see BioCentury, Ju...